Tech Company Financing Transactions
Pepticom Funding Round
Pepticom closed a Series A funding round on 1/7/2025. Investors included Japan Israel High Tech Ventures and private investors.
Transaction Overview
Company Name
Announced On
1/7/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Japan Israel High Tech Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the development of its oral IL-17 inhibitor program, targeting improved treatments for autoimmune diseases.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
Undisclosed
Jerusalem, Undisclosed
Israel
Jerusalem, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Pepticom, a Jerusalem, Israel-based AI-driven peptide-based therapeutics company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Immanuel Lerner
Browse more venture capital transactions:
Prev: 1/7/2025: Senseera venture capital transaction
Next: 1/7/2025: Solaxy venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs